+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pericardium Diseases Market Size, Share & Trends Analysis Report by Drug Class (NSAIDs, Colchicine), Disease Type (Acute Pericarditis, Recurrent Pericarditis), Distribution Channel and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 6214564
REQUEST CUSTOMIZATION
Description Jump to:
The global pericardium diseases market size was estimated at USD 2.96 billion in 2024 and is projected to reach USD 5.06 billion by 2033, growing at a CAGR of 6.14% from 2025 to 2033. The growth is driven by the prevalence of cardiovascular conditions, aging populations, and improved diagnostic capabilities, which are driving demand for effective treatments targeting pericardial disorders such as pericarditis, pericardial effusion, and constrictive pericarditis.

Rising awareness about early detection and management of heart-related conditions is boosting the adoption of advanced therapeutics and minimally invasive interventions. Factors such as sedentary lifestyles, chronic infections, autoimmune diseases, and post-surgical complications have also contributed to the growing disease burden.

The global pericarditis market is driven by advancements in healthcare practices, evolving lifestyles, and technological innovation. Pericarditis, characterized by inflammation of the pericardial sac, remains the most prevalent pathological condition affecting the pericardium. According to the National Library of Medicine, pericardial cases are classified into acute, incipient, subacute, chronic, and recurrent forms, accounting for an estimated 15%-30% of cases. The increasing prevalence of cardiovascular risk factors, including hypertension, autoimmune disorders, infections, and post-myocardial infarction complications, is augmenting the market opportunity.

Global Pericardium Diseases Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pericardium diseases market report based on drug class, disease type, distribution channel, and region.

Drug Class Outlook (Revenue, USD Million, 2021-2033)

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Colchicine
  • IL-1β Inhibitors
  • Corticosteroids
  • Immunosuppressant’s
  • Others

Disease Type Outlook (Revenue, USD Million, 2021-2033)

  • Recurrent Pericarditis
  • Acute Pericarditis
  • Constrictive Pericarditis

Distribution Channel Outlook (revenue, USD Million, 2021-2033)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Drug Class
1.2.2. Disease Type
1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Global Pericardium Diseases Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
Chapter 4. Global Pericardium Diseases Market: Drug Class Estimates & Trend Analysis
4.1. Drug Class Market Share, 2024 & 2033
4.2. Drug Class Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
4.4. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
4.4.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Colchicine
4.5.1. Colchicine Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. IL-1ß Inhibitors
4.6.1. IL-1ß Inhibitors Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Corticosteroids
4.7.1. Corticosteroids Market Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Immunosuppressants
4.8.1. Immunosuppressants Market Estimates and Forecasts, 2021-2033 (USD Million)
4.9. Others
4.9.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Global Pericardium Diseases Market: Disease Type Business Analysis
5.1. Disease Type Market Share, 2024 & 2033
5.2. Disease Type Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Disease Type, 2021 to 2033 (USD Million)
5.4. Recurrent Pericarditis
5.4.1. Recurrent Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Acute Pericarditis
5.5.1. Acute Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Constrictive Pericarditis
5.6.1. Constrictive Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Global Pericardium Diseases Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2033
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.4. Hospital Pharmacies
6.4.1. Hospital Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Retail Pharmacies
6.5.1. Retail Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Online Pharmacies
6.6.1. Online Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Global Pericardium Diseases Market: Regional Business Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
7.4. North America
7.4.1. North America Pericardium Diseases Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive Scenario
7.4.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive Scenario
7.4.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive Scenario
7.4.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Europe
7.5.1. Europe Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive Scenario
7.5.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive Scenario
7.5.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive Scenario
7.5.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive Scenario
7.5.5.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive Scenario
7.5.6.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. Norway
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive Scenario
7.5.7.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory framework/ reimbursement structure
7.5.8.3. Competitive Scenario
7.5.8.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9. Denmark
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory framework/ reimbursement structure
7.5.9.3. Competitive Scenario
7.5.9.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. India
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive Scenario
7.6.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive Scenario
7.6.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. Japan
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive Scenario
7.6.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. Thailand
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive Scenario
7.6.5.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive Scenario
7.6.6.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Australia
7.6.7.1. Key Country Dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive Scenario
7.6.7.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.8. Thailand
7.6.8.1. Key Country Dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive Scenario
7.6.8.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive Scenario
7.7.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive Scenario
7.7.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive Scenario
7.8.2.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive Scenario
7.8.3.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory framework/ reimbursement structure
7.8.4.3. Competitive Scenario
7.8.4.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9. UAE
7.9.1.1. Key Country Dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive Scenario
7.9.1.4. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 4 Global Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 5 Global Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 6 Global Pericardium Diseases Market, by region, 2021-2033 (USD Million)
Table 7 North America Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 8 North America Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 9 North America Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 10 US Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 11 US Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 12 US Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 13 Canada Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 14 Canada Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 15 Canada Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 16 Mexico Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 17 Mexico Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 18 Mexico Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 19 Europe Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 20 Europe Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 21 Europe Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 22 UK Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 23 UK Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 24 UK Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 25 Germany Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 26 Germany Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 27 Germany Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 28 France Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 29 France Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 30 France Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 31 Italy Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 32 Italy Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 33 Italy Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 34 Spain Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 35 Spain Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 36 Spain Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 37 Norway Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 38 Norway Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 39 Norway Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 40 Sweden Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 41 Sweden Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 42 Sweden Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 43 Denmark Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 44 Denmark Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 45 Denmark Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 46 Asia-Pacific Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 47 Asia-Pacific Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 48 Asia-Pacific Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 49 Japan Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 50 Japan Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 51 Japan Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 52 China Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 53 China Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 54 China Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 55 India Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 56 India Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 57 India Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 58 Australia Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 59 Australia Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 60 Australia Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 61 Thailand Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 62 Thailand Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 63 Thailand Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 64 South Korea Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 65 South Korea Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 66 South Korea Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 67 Latin America Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 68 Latin America Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 69 Latin America Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 70 Brazil Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 71 Brazil Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 72 Brazil Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 73 Argentina Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 74 Argentina Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 75 Argentina Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 76 Middle East & Africa Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 77 Middle East & Africa Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 78 Middle East & Africa Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 79 South Africa Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 80 South Africa Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 81 South Africa Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 82 Saudi Arabia Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 83 Saudi Arabia Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 84 Saudi Arabia Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 85 Kuwait Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 86 Kuwait Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 87 Kuwait Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
Table 88 UAE Pericardium Diseases Market, by drug class, 2021-2033 (USD Million)
Table 89 UAE Pericardium Diseases Market, by disease type, 2021-2033 (USD Million)
Table 90 UAE Pericardium Diseases Market, by distribution channel, 2021-2033 (USD Million)
List of Figures
Figure 1 Global Pericardium Diseases Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot
Figure 9 Therapeutic Approach and Disease Outlook (USD Million)
Figure 10 Competitive Landscape
Figure 11 Pericardium Diseases Market Dynamics
Figure 12 Pericardium Diseases Market Porter’s Five Forces Analysis
Figure 13 Pericardium Diseases Market PESTLE Analysis
Figure 14 Drug Class Market, 2021-2033 (USD Million)
Figure 15 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 16 Colchicine Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 17 IL-1ß Inhibitors Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 18 Corticosteroids Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 19 Immunosuppressants Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 20 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 21 Disease Type Market, 2021-2033 (USD Million)
Figure 22 Recurrent Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Acute Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Constrictive Pericarditis Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Distribution Channel Market, 2021-2033 (USD Million)
Figure 26 Hospital Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Retail Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Online Pharmacies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Regional marketplace: Key takeaways
Figure 30 North America Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 U.S. Country Dynamics
Figure 32 U.S. Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Canada Country Dynamics
Figure 34 Canada Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Mexico Country Dynamics
Figure 36 Mexico Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Europe Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 UK Country Dynamics
Figure 39 UK Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Germany Country Dynamics
Figure 41 Germany Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 France Country Dynamics
Figure 43 France Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Italy Country Dynamics
Figure 45 Italy Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Spain Country Dynamics
Figure 47 Spain Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Norway Country Dynamics
Figure 49 Norway Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Sweden Country Dynamics
Figure 51 Sweden Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Denmark Country Dynamics
Figure 53 Denmark Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Asia-Pacific Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Japan Country Dynamics
Figure 56 Japan Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 China Country Dynamics
Figure 58 China Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 India Country Dynamics
Figure 60 India Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Australia Country Dynamics
Figure 62 Australia Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Thailand Country Dynamics
Figure 64 Thailand Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 South Korea Country Dynamics
Figure 66 South Korea Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Latin America Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Argentina Country Dynamics
Figure 69 Argentina Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Brazil Country Dynamics
Figure 71 Brazil Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Middle East & Africa Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 73 Saudi Arabia Country Dynamics
Figure 74 Saudi Arabia Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 South Africa Country Dynamics
Figure 76 South Africa Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Kuwait Country Dynamics
Figure 78 Kuwait Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 UAE Country Dynamics
Figure 80 UAE Pericardium Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)

Companies Mentioned

The key companies profiled in this Pericardium Diseases market report include:
  • Kiniksa Pharmaceuticals Corp.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Novartis AG
  • Amgen Inc.
  • Takeda Pharmaceutical Company Limited
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Swedish Orphan Biovitrum AB
  • Pfizer Inc.
  • Alnylam Pharmaceuticals, Inc.
  • BridgeBio Pharma, Inc

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 2.96 Billion
Forecasted Market Value ( USD ) by 2033 $ 5.06 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Reports

U.S. Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report by Product (Balloon-expandable, Self-expandable), Leaflet Material, Frame Material, End Use (Inpatient Facilities, Outpatient Facilities), and Growth Forecasts, 2025-2033 - Product Image

U.S. Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report by Product (Balloon-expandable, Self-expandable), Leaflet Material, Frame Material, End Use (Inpatient Facilities, Outpatient Facilities), and Growth Forecasts, 2025-2033

  • Report
  • 80 Pages
  • United States
From
Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 137 Pages
  • Global
From
Diagnostic Pathology: Cardiovascular. Edition No. 3 - Product Image

Diagnostic Pathology: Cardiovascular. Edition No. 3

  • Book
Resorbable Pericardial Membrane Market - Global Forecast 2025-2030 - Product Image

Resorbable Pericardial Membrane Market - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report by Product, Leaflet Material (Bovine Pericardium, Porcine Pericardium), Frame Material, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report by Product, Leaflet Material (Bovine Pericardium, Porcine Pericardium), Frame Material, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.